Literature DB >> 23238640

Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice.

William R Proctor1, Mala Chakraborty, Lynette S Chea, Jeffrey C Morrison, Julia D Berkson, Kenrick Semple, Mohammed Bourdi, Lance R Pohl.   

Abstract

UNLABELLED: Drug-induced liver injury (DILI) is a major health issue, as it remains difficult to predict which new drugs will cause injury and who will be susceptible to this disease. This is due in part to the lack of animal models and knowledge of susceptibility factors that predispose individuals to DILI. In this regard, liver eosinophilia has often been associated with DILI, although its role remains unclear. We decided to investigate this problem in a murine model of halothane-induced liver injury (HILI). When female Balb/cJ mice were administered halothane, eosinophils were detected by flow cytometry in the liver within 12 hours and increased thereafter proportionally to liver damage. Chemokines, eotaxin-1 (CCL11) and eotaxin-2 (CCL24), which are known to attract eosinophils, increased in response to halothane treatment. The severity of HILI was decreased significantly when the study was repeated in wildtype mice made deficient in eosinophils with a depleting antibody and in eosinophil lineage-ablated ΔdblGata(-/-) mice. Moreover, depletion of neutrophils by pretreating animals with Gr-1 antibody prior to halothane administration failed to reduce the severity of HILI at antibody concentrations that did not affect hepatic eosinophils. Immunohistochemical staining for the granule protein, major basic protein, revealed that eosinophils accumulated exclusively around areas of hepatocellular necrosis.
CONCLUSION: Our findings indicate that eosinophils have a pathologic role in HILI in mice and suggest that they may contribute similarly in many clinical cases of DILI.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23238640      PMCID: PMC3610837          DOI: 10.1002/hep.26196

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

1.  Neutrophil depletion protects against murine acetaminophen hepatotoxicity.

Authors:  Zhang-Xu Liu; Derick Han; Basuki Gunawan; Neil Kaplowitz
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

2.  Flow cytometric identification of murine neutrophils and monocytes.

Authors:  E Lagasse; I L Weissman
Journal:  J Immunol Methods       Date:  1996-10-16       Impact factor: 2.303

3.  Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.

Authors:  H Satoh; B M Martin; A H Schulick; D D Christ; J G Kenna; L R Pohl
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  A mouse model of severe halothane hepatitis based on human risk factors.

Authors:  Christine M Dugan; Allen E MacDonald; Robert A Roth; Patricia E Ganey
Journal:  J Pharmacol Exp Ther       Date:  2010-02-02       Impact factor: 4.030

5.  Eosinophil- and eosinophil granule-mediated pneumocyte injury.

Authors:  G H Ayars; L C Altman; G J Gleich; D A Loegering; C B Baker
Journal:  J Allergy Clin Immunol       Date:  1985-10       Impact factor: 10.793

6.  Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes.

Authors:  Akira Kanda; Virginie Driss; Nicolas Hornez; Marwan Abdallah; Thomas Roumier; Georges Abboud; Fanny Legrand; Delphine Staumont-Sallé; Severine Quéant; Julie Bertout; Sébastien Fleury; Patrick Rémy; Jean-Paul Papin; Valérie Julia; Monique Capron; David Dombrowicz
Journal:  J Allergy Clin Immunol       Date:  2009-06-21       Impact factor: 10.793

7.  Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes.

Authors:  Barbara Jaruga; Feng Hong; Rui Sun; Svetlana Radaeva; Bin Gao
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

8.  Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice.

Authors:  Hubert Louis; Alain Le Moine; Véronique Flamand; Nathalie Nagy; Eric Quertinmont; Frédéric Paulart; Daniel Abramowicz; Olivier Le Moine; Michel Goldman; Jacques Devière
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

9.  Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity.

Authors:  Guruprasad P Aithal; Lesley Ramsay; Ann K Daly; Nhareet Sonchit; Julian B S Leathart; Graeme Alexander; J Gerald Kenna; John Caldwell; Christopher P Day
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

10.  Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C.

Authors:  G Tarantino; D Cabibi; C Cammà; N Alessi; M Donatelli; S Petta; A Craxì; V Di Marco
Journal:  J Viral Hepat       Date:  2008-02-05       Impact factor: 3.728

View more
  20 in total

1.  CCR2 deficiency leads to increased eosinophils, alternative macrophage activation, and type 2 cytokine expression in adipose tissue.

Authors:  W Reid Bolus; Dario A Gutierrez; Arion J Kennedy; Emily K Anderson-Baucum; Alyssa H Hasty
Journal:  J Leukoc Biol       Date:  2015-05-01       Impact factor: 4.962

2.  Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 production.

Authors:  Yaochun Wang; Yang Yang; Meng Wang; Shuhong Wang; Jong-Min Jeong; Long Xu; Yankai Wen; Christoph Emontzpohl; Constance Lynn Atkins; Kevin Duong; Nicolas F Moreno; Xiaoyi Yuan; David R Hall; Wasim Dar; Dechun Feng; Bin Gao; Yong Xu; Zoltan Czigany; Sean P Colgan; J Steve Bynon; Shizuo Akira; Jared M Brown; Holger K Eltzschig; Elizabeth A Jacobsen; Cynthia Ju
Journal:  Sci Transl Med       Date:  2021-02-03       Impact factor: 17.956

3.  Hepatic recruitment of eosinophils and their protective function during acute liver injury.

Authors:  Long Xu; Yang Yang; Yankai Wen; Jong-Min Jeong; Christoph Emontzpohl; Constance L Atkins; Zhaoli Sun; Kyle L Poulsen; David R Hall; J Steve Bynon; Bin Gao; William M Lee; Jody Rule; Elizabeth A Jacobsen; Hua Wang; Cynthia Ju
Journal:  J Hepatol       Date:  2022-03-05       Impact factor: 30.083

4.  Thymic stromal lymphopoietin and interleukin-4 mediate the pathogenesis of halothane-induced liver injury in mice.

Authors:  William R Proctor; Mala Chakraborty; Aaron M Fullerton; Midhun C Korrapati; Pauline M Ryan; Kenrick Semple; Jeffrey C Morrison; Julia D Berkson; Lynette S Chea; Qian Yang; Albert P Li; Rosanne Spolski; Erin E West; Yrina Rochman; Warren J Leonard; Mohammed Bourdi; Lance R Pohl
Journal:  Hepatology       Date:  2014-05-20       Impact factor: 17.425

Review 5.  Xenobiotic and Endobiotic Mediated Interactions Between the Cytochrome P450 System and the Inflammatory Response in the Liver.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Adv Pharmacol       Date:  2015-05-19

6.  Halothane-induced hepatitis: paradigm or paradox for drug-induced liver injury.

Authors:  Mark J Kurth; Tsuyoshi Yokoi; M Eric Gershwin
Journal:  Hepatology       Date:  2014-09-25       Impact factor: 17.425

7.  Mechanisms of Inflammatory Liver Injury and Drug-Induced Hepatotoxicity.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Curr Pharmacol Rep       Date:  2018-06-30

Review 8.  Idiosyncratic adverse drug reactions: current concepts.

Authors:  Jack Uetrecht; Dean J Naisbitt
Journal:  Pharmacol Rev       Date:  2013-03-08       Impact factor: 25.468

Review 9.  What have we learned from animal models of idiosyncratic, drug-induced liver injury?

Authors:  Robert A Roth; Patricia E Ganey
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-05-04       Impact factor: 4.481

10.  Visualization of acute liver damage induced by cycloheximide in rats using PET with [(18)F]FEDAC, a radiotracer for translocator protein (18 kDa).

Authors:  Akiko Hatori; Joji Yui; Lin Xie; Tomoteru Yamasaki; Katsushi Kumata; Masayuki Fujinaga; Hidekatsu Wakizaka; Masanao Ogawa; Nobuki Nengaki; Kazunori Kawamura; Ming-Rong Zhang
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.